Back to catalogue
№ 082 27 filings · 2021-08-10 → 2026-06-09

BELLWAY PLC

BWY
Consumer Products and Services Share price 2,160p Market cap £2.4bn Overall fit 300 /1000

Cheap, well-capitalised UK housebuilder trading at 0.66x NAV with real 33% upside and strong downside protection, but wholly absent from the AI-receiver thesis and only moderate operating leverage — a good stock but a poor thematic fit.

Fair value range 2,400p–2,900p Mid case · £3.0bn
Absolute upside +23.1% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • Clean audited NAV of 3,005p per share with tangible land/WIP backing
  • Two independent valuation methods (P/NAV and forward P/E) converge on similar range
  • Consistent, credible management guidance with FY26 upgrade in H1
Limits the call
  • Deep cyclicality means near-term earnings sensitive to mortgage rates
  • Legacy building safety provision (£506m) could inflate further
Methodology

P/NAV with forward P/E cross-check

In one line · bull case

Well-capitalised UK housebuilder trading at 0.66x tangible NAV with an early-cycle volume recovery, £150m buyback and a plausible path to mid-teens operating margins.

In one line · biggest risk

A further leg up in UK mortgage rates or persistent build-cost inflation would delay the margin recovery and compress the valuation gap for years.

Drivers
AI beneficiary 5 /100
Zero AI angle — this is a physical UK housebuilder with no data, software or AI-supply-chain exposure.
Operating leverage 50 /100
Moderate — thin 16% gross margin means incremental revenue drops through modestly; timber-frame facility is the main embedded margin lever.
Earnings vs expectations 60 /100
Generally meets/small beats vs own guidance; FY26 volume guidance raised at H1 from ~9,200 to 9,300–9,500.
Growth momentum 55 /100
Early-cycle recovery — targeting 10,000 homes by FY28 vs 8,749 in FY25, but sensitive to mortgage-rate path.
Moat 35 /100
Limited — scale, brand and land bank matter but the product is largely commoditised and margins converge across peers.
Earnings quality 60 /100
Underlying vs statutory divergence driven by large legacy building-safety provision, but cash generation and disclosure are solid.
Management quality 65 /100
Long-tenured team, credible guidance, disciplined capital allocation with £150m buyback and stretch RoE targets.
Cyclicality 85 /100
Deeply cyclical UK housebuilder — volumes swung from 11,198 (FY22) to 7,654 (FY24) and back to 8,749 (FY25).
Leverage 20 /100
Low — net debt £236m against £3.5bn equity; adjusted gearing 10.3%; £400m committed bank facility unused.
Value-trap signals · 4
  • Legacy building safety provision has grown (2023 £480m → 2025 £516m)
  • Dividend cut from 140p in FY23 to 70p in FY25 reflects cyclicality
  • Persistent UK planning-system and mortgage-affordability headwinds
  • Low ROE profile (underlying pre-tax RoE only 8.2% in FY25)

BELLWAY PLC (BWY) — Investment Research Note

Executive summary

Bellway is one of the UK's largest volume housebuilders, delivering around 8,700–9,500 homes per year across England, Scotland and Wales, at an average selling price of ~£322k. Across the five-year period, the group rode a cyclical peak (FY22: 11,198 homes, 18.5% underlying operating margin), a sharp downturn (FY24: 7,654 homes, 10.0% margin) and is now in an early-cycle recovery (FY25: 8,749 homes; FY26 guidance 9,300–9,500 homes at ~10.5% margin). The single most important valuation point today is that the shares (1,988p) trade at ~0.66× tangible NAV (3,005p at 31 Jan 2026) despite a net-debt-light balance sheet, a £150m buyback underway and a credible path back to mid-teens operating margins if the mortgage market normalises.

Fair value estimate

  • Range: 2,400p – 2,900p per share (implied market cap £2,702m – £3,265m in GBP)
  • Methodology: primarily P/NAV with a cross-check on forward P/E. NAV is 3,005p 2026-03 interims. UK housebuilders in mid-cycle typically trade 0.9–1.1× NAV; a conservative 0.80–0.95× NAV gives 2,400p–2,855p. FY26E underlying EPS ~185–195p (£320–330m OP, less ~£20m interest, 28.7% tax, 112.6m shares) at 13–15× gives 2,405–2,925p — the two methods converge.
  • Central case ~2,650p implies mkt cap ~£2,984m vs current £2,237.6m.
  • Absolute upside: ~33% to midpoint (range +21% to +46%).

Sector context

Confirmed as Consumer Discretionary / Consumer Products & Services (UK housebuilder). Bellway sits in line with typical UK housebuilder peers on quality: fortress-lite balance sheet (net debt ~£236m vs equity £3.5bn), 5-star HBF customer rating for 10 consecutive years, but margins currently ~500bps below peak. Listed peers: Persimmon (PSN), Taylor Wimpey (TW.), Barratt Redrow (BTRW), Berkeley Group (BKG).

Investment thesis (3 bullets)

  • Deep discount to a real, low-encumbered NAV. NAV per share is 3,005p vs 1,988p share price — a 34% discount 2026-03 interims. The balance sheet is comfortably capitalised with modest net debt (£236m at May 2026), £400m committed bank facility, and 10.3% adjusted gearing. Management is signalling confidence by executing a £150m buyback 2025-10 FY results.
  • Operating leverage to a housing-market normalisation. Management explicitly targets mid-teens underlying operating margin (vs 10.5% run-rate) and 10,000 homes by FY28 with a stretch pre-tax RoE target of 14% built into a new LTIP 2025-10 FY results. Volumes are already rising (FY25 +14%, FY26 guided +6–9%). Even modest mortgage-rate easing and outlet growth should compound into disproportionate profit growth.
  • Well-invested land bank and capital efficiency drive. 94,393 plots with over half strategically sourced; the WIP balance has already declined 3% since FY25 year-end, signalling asset-turn improvement 2026-03 interims. A new proprietary timber-frame facility ("Bellway Home Space") opened Jan 2026 to lift efficiency and margins over the medium term.

Key risks (3 bullets)

  • Deep cyclicality and mortgage-rate sensitivity. The June 2026 trading update flagged softer April–May reservations after mortgage rates ticked up, with FY27 outlook explicitly uncertain 2026-06 trading update. History shows revenue swings of 30%+ peak-to-trough (FY22 £3.5bn → FY24 £2.4bn).
  • Legacy building-safety provision of £506.5m still unwinding, with £27m added in H1 FY26 alone from cost overruns 2026-03 interims. Estimates could inflate further as more buildings are surveyed under the SRT.
  • Build-cost re-inflation. June 2026 update flagged renewed material-cost pressure and supplier surcharges tied to energy/fuel 2026-06 trading update. Given the fragile 10.5% operating margin, further inflation without price offset would compress returns.

Operating leverage

Bellway is a moderate-operating-leverage business, not a high one. The FY25 cost structure was roughly: cost of sales £2,326m (fully variable, dominated by land and build costs) and underlying admin £152m (largely fixed) on £2,783m revenue. Gross margin at 16.4% is thin relative to a software or platform business; incremental revenue therefore drops through at roughly gross margin, less the small amount of admin absorbed. Management commentary confirms this — they guide that a return to peak volumes with modest ASP support would deliver mid-teens operating margin (a ~500bps expansion). Practically: a 10-20% revenue beat vs the FY26 £320–330m OP guidance would likely translate to ~30-50% incremental OP growth as volumes fill fixed overhead and land-bank amortisation. Not the "multiples of profit" that pure fixed-cost software delivers, but meaningful. The genuine inflection lever is the timber-frame facility (targeted 30% of output by 2030 vs 14% now) which management says will lift asset turn and margin — this is the one embedded platform-style dynamic in the business 2025-10 FY results.

Value-trap signals

  • Persistent structural headwinds in UK housing: planning delays, end of Help-to-Buy, mortgage affordability, first-time-buyer weakness.
  • Legacy building-safety liabilities have grown (2023 £480m → 2025 £516m); could grow further.
  • CMA competition investigation concluded with a £13.5m voluntary contribution; not systemic but ongoing regulatory scrutiny of the sector.
  • ROE structurally low (underlying pre-tax RoE 8.2% in FY25) — the business is capital-heavy and returns modest relative to cost of capital.
  • Dividend cut in FY24 (70p total FY25 vs 140p FY23) — reflects the cycle rather than a stress signal, but investors buying for yield have already been disappointed.

Earnings vs expectations

Across the filings the pattern is one of honest, generally-met guidance with modest recent upgrades. FY24 delivered 7,654 homes and ~10% margin, exactly matching June 2024 profit-estimate guidance. FY25 delivered 8,749 homes vs "at least 8,500" guided at the interims — a modest beat on volumes with margin also slightly ahead. In FY26, management raised volume guidance at H1 (from ~9,200 to 9,300–9,500) and reiterated the £320–330m operating profit range in the June trading update despite softer April/May demand 2026-06 trading update. Overall: management is credible, no material misses in the period, with a small upward bias.

Conviction

Conviction: 4 (high). Housebuilder valuations anchor on tangible NAV, and Bellway's £3.5bn NAV is well-supported by land at historic cost (£2.5bn) and WIP (£2.1bn), with all major liabilities (£506m legacy building safety) explicitly reserved. Two independent methods (P/NAV and forward P/E) converge on the fair-value range. Anchors: (1) clean disclosure and audited FY25 accounts, (2) two well-established valuation methods that agree, (3) explicit management targets for FY28. Limiters: (1) macro sensitivity — mortgage rates and consumer confidence could push the recovery timeline out, (2) legacy building-safety provision could still expand.

Overall score rationale

This is a fundamentally attractive UK housebuilder at ~0.66× NAV with real upside, but it fails the investor's core criterion of AI-receiver exposure entirely — Bellway sells physical houses. Operating leverage is moderate, not high. Downside protection is strong (net-cash-like balance sheet, tangible NAV). Score reflects "cheap and safe but wrong-thesis."

Filings consulted · 32

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-06-09Trading Update2026-06-09_9607671_trading-update.md0.85
  2. 2026-03-24Interim Results Announcement2026-03-24_9487795_interim-results-announcement.md0.90
  3. 2026-02-10Trading Update2026-02-10_9422429_trading-update.md0.85
  4. 2025-11-27Result OF Agm2025-11-27_9261889_result-of-agm.md0.26
  5. 2025-10-272025 Annual Report And Accounts And Notice OF Agm2025-10-27_9194950_2025-annual-report-and-accounts-and-notice-of-agm.md0.81
  6. 2025-10-14Full Year Results2025-10-14_9168622_full-year-results.md0.85
  7. 2025-08-12Trading Update2025-08-12_9045296_trading-update.md0.72
  8. 2025-06-10Trading Update2025-06-10_8920461_trading-update.md0.55
  9. 2025-03-25Interim Results Announcement2025-03-25_8794775_interim-results-announcement.md0.58
  10. 2025-02-11Trading Update2025-02-11_8730202_trading-update.md0.55
  11. 2024-12-12Result OF Agm2024-12-12_8607742_result-of-agm.md0.20
  12. 2024-11-112024 Annual Report And Accounts And Notice OF Agm2024-11-11_8541083_2024-annual-report-and-accounts-and-notice-of-agm.md0.62
  13. 2024-08-09Trading Update2024-08-09_8358179_trading-update.md0.55
  14. 2024-06-07Trading Update2024-06-07_8247422_trading-update.md0.38
  15. 2024-03-26Interim Results Announcement2024-03-26_8106054_interim-results-announcement.md0.41
  16. 2024-02-09Trading Update2024-02-09_8029888_trading-update.md0.38
  17. 2023-12-15Result OF Agm2023-12-15_7945172_result-of-agm.md0.14
  18. 2023-11-27Notice OF Agm Update TO Wording OF Resolution2023-11-27_7905222_notice-of-agm-update-to-wording-of-resolution.md0.14
  19. 2023-11-062023 Annual Report And Accounts And Notice OF Agm2023-11-06_7861391_2023-annual-report-and-accounts-and-notice-of-agm.md0.43
  20. 2023-08-09Trading Update2023-08-09_7684436_trading-update.md0.38
  21. 2023-06-13Trading Update2023-06-13_7571333_trading-update.md0.21
  22. 2023-03-28Interim Results Announcement2023-03-28_7335559_interim-results-announcement.md0.23
  23. 2023-02-09Trading Update2023-02-09_7403954_trading-update.md0.21
  24. 2022-12-16Result OF Agm2022-12-16_7446289_result-of-agm.md0.07
  25. 2022-11-072022 Annual Report And Accounts And Notice OF Agm2022-11-07_7294546_2022-annual-report-and-accounts-and-notice-of-agm.md0.24
  26. 2022-08-09Trading Update2022-08-09_7054523_trading-update.md0.21
  27. 2022-06-14Trading Update2022-06-14_6939469_trading-update.md0.21
  28. 2022-03-29Interim Results Announcement2022-03-29_7091774_interim-results-announcement.md0.23
  29. 2022-02-08Trading Update2022-02-08_6749102_trading-update.md0.21
  30. 2021-12-06Result OF Agm2021-12-06_6753933_result-of-agm.md0.07
  31. 2021-11-042021 Annual Report And Accounts And Notice OF Agm2021-11-04_6660697_2021-annual-report-and-accounts-and-notice-of-agm.md0.24
  32. 2021-08-10Trading Update2021-08-10_6497546_trading-update.md0.21

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-08-10 and 2026-06-09. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.